RDIF and Panacea Begin Production of Sputnik Vax

The Russian Direct Investment Fund and Indian drug firm Panacea Biotec announced the launch of production of the Sputnik V coronavirus vaccine in India. The first batch of the Covid-19 vaccine produced at Panacea Biotec's facilities at Baddi in Himachal Pradesh will be shipped to the Russia's Gamaleya Center for quality control. Full-scale production of the vaccine is expected to start this summer, RDIF and Panacea Biotec said in a joint statement. 

No comments: